Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 506943 | NSE Symbol : JBCHEPHARM | ISIN : INE572A01036 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Profit and Loss

Particulars (₹ Cr)	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Revenue From Operations	3,722.92	3,298.64	2,884.16	2,189.88	1,892.00
Sale of Products	3,655.72	3,251.81	2,852.64	2,158.74	1,839.21
Sale of Services	16.62	11.40	2.79	3.66	9.87
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	50.58	35.43	28.74	27.48	42.92
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	3,722.92	3,298.64	2,884.16	2,189.88	1,892.00
Other Income	34.74	34.67	8.65	38.61	115.92
Total Revenue	3,757.66	3,333.32	2,892.81	2,228.49	2,007.92
Changes in Inventories	15.53	-49.22	-27.48	-25.57	-15.70
Cost of Material Consumed	820.04	816.05	783.78	601.87	542.17
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	416.66	342.25	280.43	167.40	99.29
Employee Benefits	646.79	565.38	499.95	399.06	305.98
Total Other Expenses	805.97	744.77	682.80	538.21	407.93
Manufacturing / Operating Expenses	227.62	208.88	197.56	168.72	147.29
Administrative and Selling Expenses	491.43	446.93	394.90	305.91	204.68
Other Expenses	86.92	88.96	90.33	63.58	55.96
Finance Costs	9.12	40.52	34.31	4.95	7.19
Depreciation and Amortization	166.45	135.24	111.99	71.28	67.36
Total Expenses	2,880.56	2,594.98	2,365.77	1,757.20	1,414.21
Profit Before Exceptional Items and Tax	877.11	738.34	527.04	471.29	593.71
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	877.11	738.34	527.04	471.29	593.71
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	877.11	738.34	527.04	471.29	593.71
Taxation	224.56	194.98	138.15	110.29	146.62
Current Tax	193.70	145.10	83.35	122.50	137.50
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	32.88	49.49	54.80	-12.21	9.12
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	-2.01	0.39	0.00	0.00	0.00
Profit After Tax	652.54	543.36	388.89	361.00	447.08
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	652.54	543.36	388.89	361.00	447.08
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	652.54	543.36	388.89	361.00	447.08
Earning Per Share - Basic	42.00	35.07	25.15	46.71	57.85
Earning Per Share - Diluted	41.16	34.30	24.85	46.67	57.85

LOGIN HERE

LOGIN HERE

J B Chemicals & Pharmaceuticals Ltd

Profit and Loss